Gary has 25 years of experience in the pharmaceutical industry, including roles at AstraZeneca, Redx Pharma, Cyprotex. His extensive expertise includes establishing in vitro assays, leading ADME client services, and providing insights and guidance for a wide range of drug discovery programs.
